E2 ModeratePreliminaryPEM ?ObservationalPeer-reviewedMachine draft
The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome.
Masuda, Akinori, Nakayama, Takashi, Yamanaka, Takao et al. · Journal of behavioral medicine · 2002 · DOI
Quick Summary
This study compared two types of ME/CFS patients: those whose illness started after an infection and those whose didn't. After multidisciplinary treatment, patients who developed ME/CFS after infection showed better improvement in symptoms and were more likely to return to work. Importantly, a marker of immune function called NK cell activity also showed more improvement in the post-infectious group, suggesting their bodies may respond differently to treatment.
Why It Matters
This study suggests that ME/CFS may be a heterogeneous disease with distinct subtypes that respond differently to treatment, which could guide personalized clinical approaches. The observation that post-infectious ME/CFS has better prognosis may help patients and clinicians set realistic expectations and tailor interventions accordingly.
Observed Findings
- Post-infectious CFS group showed increased NK cell activity after treatment; post-infectious CFS group showed improved physical and mental symptoms; 8 of 9 post-infectious CFS patients returned to work; non-infectious CFS group showed no NK cell activity recovery; only 3 of 9 non-infectious CFS patients returned to work.
Inferred Conclusions
- Classification of CFS into post-infectious and non-infectious subtypes is clinically useful for treatment planning. Post-infectious CFS has a more favorable prognosis than non-infectious CFS following multidisciplinary treatment. NK cell activity recovery may be associated with better clinical outcomes in post-infectious CFS.
Remaining Questions
- What specific components of the multidisciplinary treatment were most effective for each CFS subtype? Why does post-infectious CFS show different immune recovery patterns than non-infectious CFS? Would these findings replicate in larger, more diverse patient populations with longer follow-up periods? What mechanisms explain the differential treatment response between the two groups?
What This Study Does Not Prove
This small observational study does not establish causation for the better outcomes in post-infectious CFS, nor does it prove the underlying mechanisms. The lack of a control group and undefined multidisciplinary treatment make it impossible to determine which specific interventions drove improvements, and results may not generalize beyond this specific population.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:Blood Biomarker
Phenotype:Infection-Triggered
Method Flag:Weak Case DefinitionNo ControlsSmall SampleMixed Cohort
Metadata
- DOI
- 10.1023/a:1020475108745
- PMID
- 12442563
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026